Joshua Krass, DO
Neurological Surgery · Kalispell, MTNPI 1275654386
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $2,200 of the $3,196 with a category attached, or 68.8%. 7 manufacturers reported payments, led by Globus Medical at 56.4% of the total. That places this record below the midpoint for neurological surgery clinicians in MT, where the typical reported total is $3,333.
Across 19 payments — averaging $168.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Globus Medical$2K
- Monteris Medical Corporation$940
- Medtronic$195
- GT Medical Technologies, Inc$111
- Johnson & Johnson$83
- Integra Lifesciences Corporation$52
- plus $14 from 1 others
What the payments were for
- Travel & lodging$2,20069%
- Food & beverage$89828%
- Education$983%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Globus Medical | 6 | $1,803 |
| Monteris Medical Corporation | 5 | $940 |
| Medtronic | 3 | $195 |
| GT Medical Technologies, Inc | 1 | $111 |
| Johnson & Johnson | 1 | $83 |
| Integra Lifesciences Corporation | 2 | $52 |
| AbbVie | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ELSA$1,744
- Neuroblate$786
- GammaTile$111
How this compares
$3,196 in reported general payments places this provider in the 45th percentile of 31 neurological surgery providers in Montana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pregabalin | 45 | $1,173 |
| Gabapentin | 83 | $686 |
| Oxycodone Hcl | 45 | $470 |
| Celecoxib | 16 | $257 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 18 | $230 |
| Meloxicam | 41 | $165 |
| Cyclobenzaprine Hcl | 17 | $157 |
| Methocarbamol | 17 | $119 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 13 | $75 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Kalispell
- Frank BishopKalispell$8K
- Joseph SramekKalispell$6K
- Kelly SchmidtKalispell$5K
- Thomas OrigitanoKalispell$5K
- Stephen CampbellKalispell$183
- Patrick BurnsKalispell$63
- Raymond TurnerBillings$1.3M
- Carter BeckMissoula$272K
- Marlin RichardsonBillings$35K
- Stuart GoodmanBillings$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.